TG Therapeutics Inc (FRA:NKB2)
€ 46.9 -2 (-4.09%) Market Cap: 7.22 Bil Enterprise Value: 7.39 Bil PE Ratio: 20.08 PB Ratio: 13.94 GF Score: 58/100

TG Therapeutics Inc (FRA:NKB2) Transcripts

  • 1